A cDNA encoding the murine Ah receptor (Ahl' allele for aromatic hydrocarbon responsiveness) has been isolated and characterized. Analysis of the deduced protein sequence revealed a region with imiarity to the basic regnon/helix-oop-helix (BR/HLH) motif found in many transcription factors that undergo dimerization for function. In addition to the BR/HLH domain, the N-terminal domain ofthe Ah receptor has extensive sequence simiarit to the human ARNT (aryl hydrocarbon receptor nuclear anslocator) protein and two regulatory proteins of Drosophila, Sim and Per. Photoaffinity lbeling and peptide mapping studies indicate that the Ah receptor binds agonist at a domain that lies within this conserved N-terminal domain. The Ah receptor appears to be a ligand-activated transcription factor with a helix-oophelix motif similar to those found in a variety of DNA-binding proteins, incudng Myc and MyoD.
The Ah receptor is a ligand-activated transcription factor that interacts with enhancer elements located 5' to regulated promoters, leading to increased transcription of a number of genes, including those encoding cytochrome P4501A1, the glutathione S-transferase Ya subunit, and NAD(P)H:quinone redUctase (1) (2) (3) . One of the most potent agonists of the Ah receptor is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD or "dioxin"). TCDD is the prototype for a large family of highly toxic environmental contaminants. Members of this family include a number of halogenated dibenzo-p-dioxin, dibenzofuran, and biphenyl isomers, which inducei a variety of receptor-mediated toxic responses, including a severe wasting syndrome, epidermal hyperplasia and metaplasia, tumor promotion, and thymic involution.
We have previously demonstrated that the photoaffinity ligand 2-azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin covalently labels the Ah receptor from a number of species, tissues, and cell types (ref. 4 ; unpublished observations).
These ligand-binding studies demonstrated that the Ah receptor exhibits significant molecular weight polymorphism and that four different allelic forms of the Ah receptor are present in inbred strains of mice: Ahb-' allele (C57 strains) encodes a 95-kDa Ah receptor, Ahb-2 allele (e.g., C3H strain) encodes a 104-kDa receptor, Ahb-3 allele (Mus spretus) encodes a 105-kDa receptor, and Ahd allele (e.g., DBA strain) encodes a 104-kDa receptor. The Ahd allele encodes a receptor with a lower affinity for agonist by 1-2 orders of magnitude than the Ahb-' or Ahb-2 alleles (5, 6).
We have recently described the purification of the Ah receptor from C57BL/6J mouse liver (7) . To confirm the identity of the purified protein, we sequenced its N-terminal amino acids and raised antibodies against the corresponding peptide (7, 8) . These antibodies immunoprecipitated the receptor from solution and cross-reacted with the Ah receptor on Western blots. In this report, we describe the use ofthe receptor's N-terminal amino acid sequence in the cloning and characterization of the Ah receptor's cDNA (AhbW-allele). § MATERIALS AND METHODS General. Cell lines were obtained from J. P. Whitlock, Jr. (Stanford University). The Ah receptor was photoaffinity labeled with 2-azido-3-[1251]iodo-7,8-dibromodibenzo-pdioxin as described (4) . Rabbit immunoglobulins raised against synthetic peptides corresponding to residues 12-31 and residues 233-250 were prepared and affinity-purified as described (8) . The numbering of amino acid residues given throughout the paper was determined by counting from the putative initiation methionine, not the true N-terminal residue of the protein (Ala-10) as determined from amino acid sequencing (8) .
DNA Cioning and Characterization. The oligonucleotide probe OL-18 was designed from the deduced nucleotide sequence that encoded the amino acid sequence from Lys-16 through Lys-31 of the protein's amino terminus (see Fig. 2 ). The nucleotide sequence was the reverse complement and read 5'-TTIATICCYTCIGCIGGIATIGGYTTIACIGTYT-TYTGIACIGGYTT-3', where I is inosine and Y is T or C. The probe OL-2 was designed from amino acid sequence from Lys-16 through Thr-21 and reads AARCCNGTNCAR-AARAC, where N is A, C, G, orT and Ris A orG. The probe OL-27 was derived from the open reading frame (ORF) of the genomic clone described below. OL-27 corresponds to the reverse-complement of the nucleotides encoding through Pro-34 and reads 5'-GGATTTGACTTAATTCCT-TCAGCGGG-3'. The genomic library was constructed in the Lambda FIX II vector and was obtained from Stratagene. We constructed the cDNA libraries in the Lambda ZAP II vector from random-primed mRNA obtained from murine Hepa 1c1c7 cells (9, 10) . Library screening and nucleotide sequence analysis was performed as described (11, 12) . RNA was run on formaldehyde/agarose gels and transferred to nitrocellulose membranes. Hybridization was for 16 hr with either the random-primed 0.42-kilobase (kb) or the 1.4-kb EcoRI fragment of Ah receptor cDNA clone cAhl (see Fig.   2 ) (11) .
CNBr Cleavage and Amino Acid Sequence Analysis. Photoaffinity labeled receptor, 500 pmol purified from C57BL/6J mouse liver, was dissolved in 100 y4 of 70%6 formic acid. CNBr was added, and the cleavage reaction was carried out at room temperature in the dark under nitrogen for acid sequencing experiments. Underlined residues correspond to the amino acid sequences determined from the purified protein. Sequences from which synthetic peptides were designed for antibody production are doubly underlined. The symbol (a, below top line) is inserted to indicate the position of the true N-terminal residue of the protein as found in vivo. The splice site identified in the genomic clone is presented within parentheses, with the-flanking GT and AG residues indicating the consensus donor and acceptor sites. Conditions for PCR were as described (20) . The 5' primer was 5'-GG-CTAAGCTTATGAGCAGCGGCGCCAACATCA-3' and the 3' primer was 5'-GTAGGGGATCCATTATGG-GAGAG-3'. Twenty picomoles of each primer and 100 ng of cDNA were used in 35 cycles of PCR with denaturation for 1 min at 950(, annealing at 600(2 for 1 mmn, and extension at 720(2 for 1 mmn. NaCl/0.015 M sodium citrate, pH 7). Analysis of the hybridizing region revealed an ORF that began with a sequence that matched the reported N-terminal sequence exactly between amino acids 22 and 36 (Fig. 2) . Further sequence analysis of this same genomic clone with a second oligonucleotide (OL-2) as a primer revealed an upstream ORF that contained the sequence coding for amino acids 1-21 ofthe Ah receptor's N terminus. The presence of consensus splice donor and acceptor sites at the 3' end of the upstream ORF and the 5' end of the downstream ORF identified the potential boundaries of these adjacent exons.
To obtain the Ah-receptor cDNA, we designed a perfectly matched 26-base oligonucleotide probe (OL-27) from the downstream ORF of the genomic clone. This probe was used to screen 6 x 105 recombinants of a cDNA library (650C, 2 x SSC) and a single clone was isolated. Analysis of this clone, cAhl, revealed a 1.8-kb insert containing a continuous ORF coding for 609 amino acids (Fig. 2) . To obtain additional sequence information, cAhl was used as a probe to rescreen the mouse cDNA library. An additional 1 x 106 recombinants were screened, and two overlapping clones, cAh3A and cAh4A, were isolated (Fig. 3) . Sequence analysis of cAh3A (2.0-kb insert) extended the ORF an additional 171 amino acids to an in-frame termination codon (TGA) at nucleotide 2416 of the cDNA. The clone cAh4A contained a 0.84-kb insert that overlapped with both the 3' end of cAhl and the 5' end of cAh3A. After screening an additional 2 x 106 plaques, we were unable to obtain a clone encoding the 5' region of the cDNA (encoding the initiating methionine and amino acids 1-26). Therefore, we analyzed the genomic sequence 5' to the upstream ORF and identified a putative upstream initiating methionine within a consensus sequence for translational initiation (21) . To confirm that this sequence was in fact in the cDNA, we designed primers from this sequence and used the PCR (20) to amplify this sequence out of poly(A)+ RNA. The amplified fragment was subcloned into pBluescript SK (clone cAhPCR1; Fig. 3 ) and was se- (Lower) The blots were stripped and reprobed with a glyceraldehyde phosphate dehydrogenase (GAPD) probe as a loading control.
quenced to confirm its presence in the full-length cDNA (mRNA). Because ofthe potential for additional translational start sites upstream, we can only tentatively assign translational initiation to this site.
The four cDNA clones of the Ah receptor encode a protein of 805 amino acids (Fig. 2) . From our knowledge of the N-terminal amino acid sequence of this protein, we conclude that the Ah receptor, as found in vivo (i.e., after cleavage of a leader peptide and the initiation methionine), is a 796-amino acid protein with a calculated molecular weight of 89,426 and an isoelectric point of 5.98. This calculated molecular weight is within 6% of the 95-kDa estimated from mobility in SDS/PAGE (8) , and the predicted pI is similar to that recently reported by two-dimensional gel electrophoresis of the protein, 5.2-5.7 (22) .
To determine if the pattern of mRNA expression corresponded to the pattern of receptor expression at the protein level, we performed Northern blot analysis on RNA isolated from Hepa 1c1c7 cells and the class I mutants. With either the 0.42-kb (Fig. 4) (24) . n.a., Not applicable. All amino acid sequences were determined without prior knowledge of the cDNA sequence. Positions of discrepancy are underlined. In the 7-kDa fragment a miscall of threonine instead of methionine probably resulted from the inefficient cleavage at the methionine-threonine bond (23) . The call of only one leucine residue instead of two at position 13 of this sequence was associated with a phasing problems during this sequence run. In the PVDF/CNBr procedure, the assignment of an alanine instead of lysine is attributable to the oxidation of phenylthiohydantoin-conjugated lysine, which prevents the accurate sequencing of lysine residues by this method (unpublished observation). The miscall of alanine at the fifth position of the PVDF/CNBr sequence remains unresolved.
Biochemistry: Burbach et al. -5.4 kb was detected in the Hepa 1c1c7 cells. A minor band of -5.0 kb was also present and may represent an alternatively spliced, initiated, or polyadenylylated transcript. The class I mutants, which express a very low level of the Ah-receptor protein (Fig. 1) , have undetectable expression of this 5.4-kb (or 5.0-kb) message under these same analysis conditions (Fig. 4) .
To add further support to the identity of this cDNA, we purified additional Ah receptor and performed amino acid microsequencing on internal fiagments generated by CNBr cleavage (23, 24) . Comparison ofthese amino acid sequences with those encoded by the Ah-receptor cDNA revealed four identities (compare Figs. 2 and 5 Lower). In addition, the size of each sequenced CNBr fragment, as observed on SDS/ PAGE, agrees with that predicted from the molecular weights of the constituent amino acids (Fig. 5 Lower). To further confirm the cDNA identity, we raised polyclonal antisera against synthetic peptides corresponding to the sequences from Arg-12 through Lys-31 and from Phe-233 through Gly-250. Antibodies raised against these two peptides crossreacted with the Ah receptor on Western blots and immunoprecipitated the protein from solution (ref. 8 ; data not shown).
The CNBr fragmentation experiments provided initial insights into the domain structure of the Ah receptor. By photoaffinity-labeling the Ah receptor prior to cleavage with CNBr, the region ofthe protein that was covalently bound by radioligand was identified. The autoradiogram of the CNBr fragments ( Fig. 5 Upper Left) identifies the 12-kDa band as the major photoaffinity labeled fragment (>90%o ofradiolabel after purification). This locates the photoaffinity ligandbound residue(s) of the Ah receptor to amino acids 232-334 as defined by the sequence known to follow Met-231 and the predicted C-terminal cleavage site, Met-334. This suggests that this region lies near the ligand-binding domain of the Ah receptor.
AHR (27) Fig. 6 . The putative BR/HLH domain identified in the Ah-receptor deviates from the consensus sequence defined for this domain (Fig. 8) . The BR/HLH domain has been described in manly transcription factors and has been shown to mediate both protein dimerization and DNA binding (30 (26) .
In addition to the sequence similarity at their N termini, the Ah receptor, Sim, and ARNT all have glutamine-rich C termini (Fig. 6 ). Glutamine-rich sequences have been characterized as activation domains and are described in several transcription factors (e.g., refs. 32 and 33). The presence of this domain in the Ah receptor and ARNT suggests that both proteins may be involved in the transcriptional activation of dioxin-responsive genes. Similar glutamine-rich regions have been described in several developmentally regulated and tissue-specific gene products from Drosophila to humans. These regions have been termed opa repeats and are defined at the nucleotide level as CAV (also called CAX) repeats where V = G or A (encoding glutamine) or C (encoding histidine) (34) . It is important to note that when a FASTA search was performed using the Ah-receptor cDNA sequence compared to the GenBank data base, again Sim is the number one match with 61% identity to the Ah receptor over a stretch of 116 nucleotides. Interestingly, the match is no longer at the 5' end of the cDNAs (N-terminal region) but lies in the 3' end within the CAV repeats ("opa-like" region).
Conclusion. We describe the cloning of a cDNA that encodes the murine Ah receptor (Ah"' allele). To support our conclusion, we report that this cDNA encodes four amino acid sequences found in CNBr fragments of the purified receptor and that one of these fragments is specifically labeled with the photoaffinity ligand 2-azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin (Fig. 5) . We also report that this cDNA is encoded by an mRNA species that is highly expressed in wild-type Hepa lclc7 cells and poorly expressed in class I mutant cells known to be receptor deficient (Fig. 4) . Previous work also supports the identity of this cDNA, including the observations that the photoaffinity-labeled protein interacts with dioxin-responsive elements following ligand binding (31, 35) and is encoded by the genetic locus responsible for the agonist-"responsive" or agonist-"nonresponsive" phenotype found in the murine system (i.e., the Ah locus) (36, 37) .
